Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 1 595 IDR 3.91% Market Closed
Market Cap: 24.5T IDR
Have any thoughts about
Medikaloka Hermina Tbk PT?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

1.3T
-5%
Operating Cash Flow
Growth Rates:
1 Year
+12%
3 Years
+124%
5 Years
+392%
7 Years
-
10 Years
-
-2.4T
-10%
Investing Cash Flow
Growth Rates:
1 Year
-71%
3 Years
-131%
5 Years
-294%
7 Years
-
10 Years
-
819.6B
+0.7%
Financing Cash Flow
Growth Rates:
1 Year
+120%
3 Years
-
5 Years
+94%
7 Years
-
10 Years
-

Cash Flow Statement
Medikaloka Hermina Tbk PT

Rotate your device to view
Cash Flow Statement
Currency: IDR
Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Cash Taxes Paid
(136 948)
(107 069)
(120 065)
(108 262)
(92 966)
(131 680)
(115 652)
(128 676)
(127 665)
(158 763)
(172 229)
(213 247)
(209 538)
(293 008)
(287 764)
(262 133)
(266 451)
(349 918)
(335 020)
(255 568)
(266 266)
(45 036)
(65 562)
(112 872)
(96 024)
(206 425)
(200 202)
Cash Interest Paid
(154 109)
(143 153)
(153 141)
(125 645)
(112 003)
(114 899)
(99 839)
(114 413)
(124 746)
(133 714)
(135 055)
(135 493)
(139 219)
(133 731)
(142 205)
(149 864)
(158 748)
(150 476)
(147 451)
(140 545)
(126 680)
(130 341)
(136 240)
(140 701)
(147 362)
(152 451)
(164 363)
Change in Working Capital
(1 016 215)
(834 809)
(810 863)
(971 499)
(960 356)
(1 074 767)
(1 117 436)
(1 092 111)
(1 155 909)
(1 156 373)
(1 222 337)
(1 239 431)
(1 237 467)
(1 296 118)
(1 402 985)
(1 501 493)
(1 522 923)
(1 535 857)
(1 527 761)
(1 495 566)
(1 545 361)
(1 631 322)
(1 623 256)
(1 689 063)
(1 863 431)
(1 877 580)
(1 945 452)
Cash from Operating Activities
516 220
N/A
426 124
-17%
356 960
-16%
241 671
-32%
281 638
+17%
249 389
-11%
266 934
+7%
572 580
+115%
846 451
+48%
776 577
-8%
1 233 835
+59%
1 126 485
-9%
776 409
-31%
930 786
+20%
585 680
-37%
1 856 336
+217%
1 921 469
+4%
1 892 838
-1%
2 083 345
+10%
867 738
-58%
1 044 610
+20%
1 079 147
+3%
1 167 233
+8%
1 319 655
+13%
1 391 603
+5%
1 381 139
-1%
1 311 996
-5%
Investing Cash Flow
Capital Expenditures
(970 550)
(959 366)
(821 858)
(764 162)
(610 611)
(594 537)
(612 300)
(575 942)
(604 431)
(624 641)
(748 369)
(889 652)
(1 014 278)
(1 086 265)
(1 036 271)
(1 213 544)
(1 243 836)
(1 275 771)
(1 363 005)
(1 129 010)
(1 070 949)
(1 130 793)
(1 289 945)
(1 591 359)
(1 867 421)
(2 087 103)
(2 286 000)
Other Items
(765 357)
(308 303)
(203 816)
(116 786)
(56 637)
(37 020)
9 078
(29 725)
(97 542)
(117 888)
(191 686)
(146 527)
(121 427)
(39 416)
10 327
32 065
1 588
(79 137)
(92 498)
(91 695)
(126 616)
(125 801)
(97 288)
(86 507)
(52 269)
(68 225)
(88 452)
Cash from Investing Activities
(1 735 907)
N/A
(1 267 669)
+27%
(1 025 674)
+19%
(880 948)
+14%
(667 248)
+24%
(631 557)
+5%
(603 222)
+4%
(605 667)
0%
(701 973)
-16%
(742 529)
-6%
(940 055)
-27%
(1 036 179)
-10%
(1 135 705)
-10%
(1 125 681)
+1%
(1 025 944)
+9%
(1 181 479)
-15%
(1 242 248)
-5%
(1 354 908)
-9%
(1 455 503)
-7%
(1 220 705)
+16%
(1 197 565)
+2%
(1 256 594)
-5%
(1 387 233)
-10%
(1 677 866)
-21%
(1 919 690)
-14%
(2 155 328)
-12%
(2 374 452)
-10%
Financing Cash Flow
Net Issuance of Common Stock
0
1 353 798
0
1 300 109
0
(1 300 109)
0
0
0
(28 111)
(28 111)
(40 592)
(68 873)
(118 549)
(126 430)
(228 932)
(364 033)
(241 246)
(233 366)
(95 949)
74 616
29 616
29 617
49 015
0
212 713
212 713
Net Issuance of Debt
1 028 136
85 029
(600 907)
(586 366)
(795 881)
231 727
493 458
384 530
382 487
115 530
411 565
295 565
354 919
397 740
18 437
99 462
(77 711)
68 764
120 863
65 940
278 083
344 207
474 954
517 717
423 657
865 209
772 924
Cash Paid for Dividends
0
0
0
0
0
(32 703)
(32 703)
(32 703)
0
0
(35 570)
(35 569)
0
0
(73 517)
(73 517)
0
(160 181)
(86 663)
(86 664)
0
0
(101 442)
(101 442)
0
(228 007)
(126 565)
Other
(75 681)
(310 235)
(73 811)
(93 092)
(83 573)
152 021
(38 183)
(29 286)
(35 065)
(20 777)
(31 410)
(38 388)
(39 686)
(67 361)
(59 793)
(49 929)
(40 216)
(43 463)
(28 300)
(41 931)
(35 170)
(21 532)
(30 610)
(26 814)
71 646
(35 646)
(39 459)
Cash from Financing Activities
1 268 055
N/A
1 133 433
-11%
625 391
-45%
620 651
-1%
420 655
-32%
351 045
-17%
422 572
+20%
322 541
-24%
314 719
-2%
66 642
-79%
316 474
+375%
181 016
-43%
210 791
+16%
176 261
-16%
(241 303)
N/A
(252 916)
-5%
(555 477)
-120%
(376 126)
+32%
(227 466)
+40%
(158 604)
+30%
230 865
N/A
352 291
+53%
372 519
+6%
438 476
+18%
435 693
-1%
814 269
+87%
819 613
+1%
Change in Cash
Net Change in Cash
48 368
N/A
291 888
+503%
(43 323)
N/A
(18 626)
+57%
35 045
N/A
(31 123)
N/A
86 284
N/A
289 454
+235%
459 197
+59%
100 690
-78%
610 254
+506%
271 322
-56%
(148 505)
N/A
(18 634)
+87%
(681 567)
-3 558%
421 941
N/A
123 744
-71%
161 804
+31%
400 376
+147%
(511 571)
N/A
77 910
N/A
174 844
+124%
152 519
-13%
80 265
-47%
(92 394)
N/A
40 080
N/A
(242 843)
N/A
Free Cash Flow
Free Cash Flow
(454 330)
N/A
(533 242)
-17%
(464 898)
+13%
(522 491)
-12%
(328 973)
+37%
(345 148)
-5%
(345 366)
0%
(3 362)
+99%
242 020
N/A
151 936
-37%
485 466
+220%
236 833
-51%
(237 869)
N/A
(155 479)
+35%
(450 591)
-190%
642 792
N/A
677 633
+5%
617 067
-9%
720 340
+17%
(261 272)
N/A
(26 339)
+90%
(51 646)
-96%
(122 712)
-138%
(271 704)
-121%
(475 818)
-75%
(705 964)
-48%
(974 004)
-38%

See Also

Summary
HEAL intrinsic value, competitors valuation, and company profile.
DCF Valuation
HEAL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HEAL stock valuation using valuation multiples.
Wall Street Estimates
HEAL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HEAL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.